Published in Rheumatol Int on July 02, 2014
Risk of Autoimmune Disease in Adults with Chronic Insomnia Requiring Sleep-Inducing Pills: A Population-Based Longitudinal Study. J Gen Intern Med (2016) 0.90
Current trends in salivary gland tight junctions. Tissue Barriers (2016) 0.79
Primary Sjögren's syndrome initially presenting as submandibular mucosa-associated lymphoid tissue lymphoma: A case report. Oncol Lett (2015) 0.78
Meibomian gland dysfunction patients with novel Sjögren's syndrome biomarkers benefit significantly from a single vectored thermal pulsation procedure: a retrospective analysis. Clin Ophthalmol (2017) 0.75
Clinical Efficacy and Safety of Total Glucosides of Paeony for Primary Sjögren's Syndrome: A Systematic Review. Evid Based Complement Alternat Med (2017) 0.75
Comparison of corneal biomechanics in Sjögren's syndrome and non-Sjögren's syndrome dry eyes by Scheimpflug based device. Int J Ophthalmol (2017) 0.75
American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) (2012) 4.82
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum (1999) 2.99
Treatment of primary Sjögren syndrome: a systematic review. JAMA (2010) 2.37
Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis (2013) 2.21
Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis (2011) 2.12
Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2010) 1.66
Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan. Int J Rheumatol (2012) 1.56
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study. Arthritis Res Ther (2006) 1.30
Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood (2012) 1.27
Sjögren's syndrome, the old and the new. Best Pract Res Clin Rheumatol (2012) 1.25
Novel autoantibodies in Sjogren's syndrome. Clin Immunol (2012) 1.20
Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study. Ann Rheum Dis (2004) 1.17
Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) (2009) 1.17
Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis (2012) 1.14
Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) (2005) 1.14
HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev (2011) 1.12
The liver is a common non-exocrine target in primary Sjögren's syndrome: a retrospective review. BMC Gastroenterol (2002) 1.10
Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res Ther (2011) 1.08
Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immunol (2009) 1.07
A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms. J Autoimmun (2013) 1.05
Disturbance of cytokine networks in Sjögren's syndrome. Arthritis Res Ther (2011) 1.02
Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome. Arthritis Res Ther (2011) 1.01
Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study. Ann Rheum Dis (2013) 1.00
Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces? Semin Cancer Biol (2013) 1.00
Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type. Semin Cancer Biol (2013) 1.00
Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis. Arthritis Res Ther (2008) 0.98
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes. Rheumatology (Oxford) (2013) 0.94
Neuroendocrine dysfunction in Sjogren's syndrome. Neuroimmunomodulation (2008) 0.94
Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system. Arthritis Care Res (Hoboken) (2014) 0.93
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J Autoimmun (2013) 0.93
Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren's syndrome. Ann Rheum Dis (1992) 0.92
The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review. J Autoimmun (2014) 0.92
Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. J Autoimmun (2012) 0.91
Ultrasonographic changes of major salivary glands in primary Sjogren's syndrome. Diagnostic value of a novel scoring system. Rheumatology (Oxford) (2005) 0.89
Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies. Clin Exp Immunol (2012) 0.89
IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Rα. Rheumatology (Oxford) (2012) 0.87
Autoimmune hepatitis in patients with primary Sjögren's syndrome: a series of two-hundred and two patients. Int J Clin Exp Pathol (2010) 0.85
Thyroid dysfunction in primary Sjögren's syndrome: a long-term followup study. Arthritis Rheum (2003) 0.85
Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren's syndrome. Arthritis Res Ther (2014) 0.82
Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes? Rheumatol Int (2013) 0.81
Frequency of complications and usefulness of the minor salivary gland biopsy. Reumatol Clin (2012) 0.81
Neuroendocrine manifestations in Sjögren's syndrome. Rheum Dis Clin North Am (2000) 0.80
[Anti-HCV and HCV RNA in patients with the primary Sjögren syndrome]. Przegl Epidemiol (2009) 0.79
Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome. Presse Med (2012) 0.78
A study of anti-carbonic anhydrase II antibodies in rheumatic autoimmune diseases. J Dermatol Sci (1999) 0.78
Minor salivary gland biopsy in Sjögren's syndrome: a review and introduction of a new tool to ease the procedure. Med Oral Patol Oral Cir Bucal (2014) 0.77
Significance of bone marrow edema in pathogenesis of rheumatoid arthritis. Pol J Radiol (2013) 1.14
Changes in chemical composition and antioxidative properties of rye ginger cakes during their shelf-life. Food Chem (2012) 0.95
[Efficacy and safety of TNF inhibitors--results of randomized, controlled clinical trials vs long term observational studies]. Pol Arch Med Wewn (2006) 0.77
[The role of Salmonella and Yersinia in the pathogenesis of spondyloarthropathies and rheumatoid arthritis. I. Detection of bacteria, bacterial DNA, lipopolysaccharide and ECA antigen in synovial fluid or blood]. Med Dosw Mikrobiol (2005) 0.76
[Role of Salmonella and Yersinia in the pathogenesis of spondyloarthropathies and rheumatoid arthritis. II. Antibodies to Salmonella and Yersinia in sera and synovial fluids]. Med Dosw Mikrobiol (2005) 0.75
[Amyloidosis--diagnostic difficulties. A case report of localized amyloidosis]. Wiad Lek (2011) 0.75
Musculoskeletal extraintestinal manifestations during the course of non-specific bowel diseases. Pol Przegl Chir (2013) 0.75